A more detailed description of the clinical characteristics of the CLL patients is reported in Tables 1–3, including ZAP70 and CD38 expression, cytogenetics, and IGHV mutational status. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.